Paroxysmal Atrial Fibrillation in Elderly: Worldwide Preliminary Data of LINAC-Based Stereotactic Arrhythmia Radioablation Prospective Phase II Trial

Treatment approach for elderly patients with atrial fibrillation (AF) is difficult. The present prospective phase-II trial evaluated LINAC-based stereotactic arrhythmia radioablation safety in this population. The reported data of the first 5 patients worldwide, showed no side effects, absence of AF...

Full description

Saved in:
Bibliographic Details
Published in:Frontiers in cardiovascular medicine 2022-03, Vol.9, p.832446-832446
Main Authors: Di Monaco, Antonio, Gregucci, Fabiana, Bonaparte, Ilaria, Troisi, Federica, Surgo, Alessia, Di Molfetta, Domenico, Vitulano, Nicola, Quadrini, Federico, Carbonara, Roberta, Martinelli, Gaetano, Guida, Pietro, Ciliberti, Maria Paola, Fiorentino, Alba, Grimaldi, Massimo
Format: Article
Language:English
Subjects:
arrhythmia
atrial fibrillation (AF)
Cardiovascular Medicine
elderly patients
radioablation
stereotactic body radiotherapy
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Treatment approach for elderly patients with atrial fibrillation (AF) is difficult. The present prospective phase-II trial evaluated LINAC-based stereotactic arrhythmia radioablation safety in this population. The reported data of the first 5 patients worldwide, showed no side effects, absence of AF episodes and without antiarrhythmic drugs. ClinicalTrials.gov, identifier: NCT04575662.
ISSN:2297-055X
2297-055X
DOI:10.3389/fcvm.2022.832446